Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marko Pesu

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Duodecim; Laaketieteellinen Aikakauskirja|November 16, 2010
[T-helper cells--bandleaders of immune response]Marko Pesu
Virulence|November 26, 2015
New insights into the host cell necrosis in tuberculosisMarko Pesu
Blood|October 8, 2011
Mutant JAK3 FERMents ATLLMarko Pesu
Basic & Clinical Pharmacology & Toxicology|October 30, 2013
Therapeutic targeting of the Jak/STAT pathwaySaara Aittomäki, Marko Pesu
Duodecim; Laaketieteellinen Aikakauskirja|June 21, 2016
[Innate lymphoid cells - a new group of immune cells]Anna Grönholm, Ilkka Junttila, Marko Pesu
Current Genomics|January 8, 2014
Genetics of the first seven proprotein convertase enzymes in health and diseaseHannu Turpeinen, Zsuzsanna Ortutay, Marko Pesu
European Journal of Immunology|June 5, 2003
PU.1 is required for transcriptional activation of the Stat6 response element in the Igepsilon promoterMarko Pesu, Saara Aittomäki, Tuuli Välineva, et al.
The Open Rheumatology Journal|October 3, 2012
JAK Kinases in Health and Disease: An UpdateArian Laurence, Marko Pesu, Olli Silvennoinen, et al.
Molecular Interventions|August 27, 2005
Identification of an acquired mutation in Jak2 provides molecular insights into the pathogenesis of myeloproliferative disordersMarko Pesu, John O'Shea, Lothar Hennighausen, et al.
Basic & Clinical Pharmacology & Toxicology|January 24, 2015
Regulation of Inflammatory Cytokine Production by MKP-5 in MacrophagesTuija Hömmö, Marko Pesu, Eeva Moilanen, et al.
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Duodecim; Laaketieteellinen Aikakauskirja|November 16, 2010
[T-helper cells--bandleaders of immune response]Marko Pesu
Virulence|November 26, 2015
New insights into the host cell necrosis in tuberculosisMarko Pesu
Blood|October 8, 2011
Mutant JAK3 FERMents ATLLMarko Pesu
Basic & Clinical Pharmacology & Toxicology|October 30, 2013
Therapeutic targeting of the Jak/STAT pathwaySaara Aittomäki, Marko Pesu
Duodecim; Laaketieteellinen Aikakauskirja|June 21, 2016
[Innate lymphoid cells - a new group of immune cells]Anna Grönholm, Ilkka Junttila, Marko Pesu
Current Genomics|January 8, 2014
Genetics of the first seven proprotein convertase enzymes in health and diseaseHannu Turpeinen, Zsuzsanna Ortutay, Marko Pesu
European Journal of Immunology|June 5, 2003
PU.1 is required for transcriptional activation of the Stat6 response element in the Igepsilon promoterMarko Pesu, Saara Aittomäki, Tuuli Välineva, et al.
The Open Rheumatology Journal|October 3, 2012
JAK Kinases in Health and Disease: An UpdateArian Laurence, Marko Pesu, Olli Silvennoinen, et al.
Molecular Interventions|August 27, 2005
Identification of an acquired mutation in Jak2 provides molecular insights into the pathogenesis of myeloproliferative disordersMarko Pesu, John O'Shea, Lothar Hennighausen, et al.
Basic & Clinical Pharmacology & Toxicology|January 24, 2015
Regulation of Inflammatory Cytokine Production by MKP-5 in MacrophagesTuija Hömmö, Marko Pesu, Eeva Moilanen, et al.
Pageof 6